The Next Beam: Integrating Innovations in X-Ray Imaging and DEXA Technology.

X‑ray imaging is a core modality in small‑animal life‑science research, offering non‑invasive, high‑resolution visualization of skeletal, thoracic, and limited soft‑tissue structures. These capabilities support detailed bone morphometry, device‑position verification, and dynamic imaging.
X‑ray imaging is extensively used for longitudinal skeletal phenotyping, including assessment of bone growth, mineralization defects, fracture healing, and implant integration. In pharmacology and toxicology studies, it allows repeated measurements without sacrificing animals, improving statistical power.
Despite limited soft‑tissue contrast relative to CT or MRI, X‑ray imaging remains essential due to its rapid acquisition, low dose, and compatibility with high‑throughput workflows. Cabinet systems allow safe use within BSL‑2 facilities.
DEXA is widely used in life‑science research for osteoporosis models, metabolic‑syndrome studies, sarcopenia, and evaluating drug effects on bone and adipose pathways. It delivers quantitative measurements of BMD, BMC, fat percentage, regional lean mass, and whole‑body composition with very low radiation exposure (typically <1–5 mGy), enabling repeated scans over long study periods without radiotoxic interference. Preclinical DEXA systems incorporate automated positioning, anaesthesia interfaces, and optimized ROI mapping, with scan times under one minute for high‑throughput phenotyping. Although it lacks µCT’s microarchitectural resolution, DEXA’s speed, reproducibility, low dose, and robust fat/lean discrimination make it essential for longitudinal metabolic and skeletal research.

Join our session to explore how our X-Ray imaging instruments provide top quality images and DEXA analysis without the complicated red tape of other radio imaging techniques.
Seize the moment to become a part of the future. Secure your spot- register now!”